Patents by Inventor Gerald L. Reuter

Gerald L. Reuter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6805715
    Abstract: A method and device for treating human intervertebral disc herniations using an endoscopic procedure. An access port is opened into and through the annulus of a disc to remove nucleus pulposus. Laser light fibers may then be passed through an endoscopic guide tube to anneal the inner surface of the disc annulus. Next, a balloon assembly with a valve is placed via the guide tube into the created disc space. The balloon is filled with a fluid to occupy the disc interspace or to maintain some degree of distraction of the created disc space. Post surgery, after fibrocollagenous tissue has grown into the disc space, a second endoscopic procedure is performed to remove the balloon assembly. Fluid is removed to collapse the balloon structure and then removed via the guide tube. The ingrowth of fibrocollagenous tissue will continue to fill the void formerly occupied by the balloon structure. The minimally invasive procedure of the invention allows for short term recovery and early return to normal activity.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: October 19, 2004
    Assignee: PMT Corporation
    Inventors: Merrill W. Reuter, Gerald L. Reuter, Carey D. Rehder
  • Publication number: 20030069641
    Abstract: A method and device for treating human intervertebral disc herniations using an endoscopic procedure. An access port is opened into and through the annulus of a disc to remove nucleus pulposus. Laser light fibers may then be passed through an endoscopic guide tube to anneal the inner surface of the disc annulus. Next, a balloon assembly with a valve is placed via the guide tube into the created disc space. The balloon is filled with a fluid to occupy the disc interspace or to maintain some degree of distraction of the created disc space. Post surgery, after fibrocollagenous tissue has grown into the disc space, a second endoscopic procedure is performed to remove the balloon assembly. Fluid is removed to collapse the balloon structure and then removed via the guide tube. The ingrowth of fibrocollagenous tissue will continue to fill the void formerly occupied by the balloon structure. The minimally invasive procedure of the invention allows for short term recovery and early return to normal activity.
    Type: Application
    Filed: May 16, 2002
    Publication date: April 10, 2003
    Inventors: Merrill W. Reuter, Gerald L. Reuter, Carey D. Rehder
  • Patent number: 5958445
    Abstract: This invention discloses organoleptically acceptable formulations containing non-solubilized S(+) 1,8-diethyl-1,3,4,9-tetrahydropyrano?3,4-b!indole-1-acetic acid, preferably with an acidic component, also known as S(+)etodolic acid or S(+)etodolac.
    Type: Grant
    Filed: January 14, 1998
    Date of Patent: September 28, 1999
    Assignee: American Home Products Corporation
    Inventors: Leslie G. Humber, Gerald L. Reuter
  • Patent number: 5780046
    Abstract: This invention discloses organoleptically acceptable formulations containing S(+)-2-(p-isobutylphenyl)-propionic acid, also known as S(+) ibuprofen.
    Type: Grant
    Filed: June 10, 1996
    Date of Patent: July 14, 1998
    Assignee: American Home Products Corporation
    Inventors: Leslie G. Humber, Gerald L. Reuter
  • Patent number: 5446063
    Abstract: Novel topical anesthetic compositions containing high concentrations of benzocaine in a micronized powder form suspended in an emollient vehicle.
    Type: Grant
    Filed: March 8, 1991
    Date of Patent: August 29, 1995
    Assignee: American Home Products Corporation
    Inventors: Gerald L. Reuter, Maureen M. Harrison, Mark E. Coons
  • Patent number: 4857324
    Abstract: There are provided gastric cytoprotective exogenously acidified aluminum hydroxide antacid compositions which are formed by acidifying, for example, commercial liquid antacid suspensions containing aluminum hydroxide, antacid powders or solids containing aluminum hydroxide, or aluminum hydroxide gel, to the point where the aluminum hydroxide is solubilized. The solutuions may be formulated into liquid dosage forms or spray dried and formulated into solid dosage forms.
    Type: Grant
    Filed: December 21, 1987
    Date of Patent: August 15, 1989
    Assignee: American Home Products Corporation (Del.)
    Inventors: Ghulam N. Mir, Luis E. Borella, John F. DiJoseph, Gerald L. Reuter
  • Patent number: 4835187
    Abstract: A therapeutic taste-neutral powder form a ibuprofen obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of ibuprofen and a cellulose material such as ethyl cellulose, hydroxyethyl cellulose and hydroxypropylmethyl cellulose.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: May 30, 1989
    Assignee: American Home Products Corporation
    Inventors: Gerald L. Reuter, Maureen M. Harrison
  • Patent number: 4835186
    Abstract: A therapeutic taste-neutral powder form of ibuprofen obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of ibuprofen and cellulose acetate phthalate.
    Type: Grant
    Filed: June 15, 1987
    Date of Patent: May 30, 1989
    Assignee: American Home Products Corporation
    Inventors: Gerald L. Reuter, Maureen M. Harrison
  • Patent number: 4771077
    Abstract: A therapeutic taste-neutral powder form of acetaminophen obtained by spray-drying a suspension of colloidal silica in a lower alkanol solution of acetaminophen and ethyl cellulose.
    Type: Grant
    Filed: October 21, 1986
    Date of Patent: September 13, 1988
    Assignee: American Home Products Corporation (Del.)
    Inventors: Gerald L. Reuter, Robert G. Blank
  • Patent number: 4704278
    Abstract: An aqueous antacid composition of magaldrate gel and a process for preparing same are described by the invention. The composition is prepared from and contains precipitated and undried magaldrate gel and a fluidizing of a first and second fluidizer. On fluidizer is provided by an aluminum hydroxide gel having colloidal properties and the second by a pharmaceutically acceptable citrate ion source including citric acid. The process and composition are characterized in providing a fluid, resuspendible, pharmaceutically elegant suspension possessing high antacid capacity and stability at even elevated magaldrate concentrations in addition to the ability to fluidize stiff, paste-like magaldrate gel cakes.
    Type: Grant
    Filed: August 8, 1986
    Date of Patent: November 3, 1987
    Assignee: American Home Products Corp (Del)
    Inventors: Chien-Chin Wu, Gerald L. Reuter
  • Patent number: 4676984
    Abstract: An rehydratable antacid composition of magaldrate gel and a process for preparing same are described by the invention. The composition is prepared from and contains precipitated and undried magaldrate gel, a polyhydric alcohol and fluidizing amounts of a first and second fluidizer. One fluidizer is provided by an aluminum hydroxide gel having colloidal properties and the second by a pharmaceutically acceptable citrate ion source including citric acid. The process and composition are characterized in providing rehydratable antacid composition which when admixed with water forms a fluid, resuspendible, pharmaceutically elegant suspension possessing high antacid capacity and stability at even elevated magaldrate concentrations in addition to the ability to fluidize stiff, paste-like magaldrate gel cakes.
    Type: Grant
    Filed: August 14, 1985
    Date of Patent: June 30, 1987
    Assignee: American Home Products Corp.
    Inventors: Chien-Chin Wu, Gerald L. Reuter, Mark E. Coons
  • Patent number: 4600708
    Abstract: Therapeutic liquid oral dosage formulations of propranolol hydrochloride are provided which contain lecithin and/or a basic amino acid to impart taste masking characteristics and/or contain a basic amino acid to impart anesthesia masking characteristics.
    Type: Grant
    Filed: July 19, 1985
    Date of Patent: July 15, 1986
    Assignee: American Home Products Corporation
    Inventors: Gerald L. Reuter, Mark E. Coons
  • Patent number: 4011312
    Abstract: A prolonged release drug dosage form for the treatment of bovine mastitis, specifically suited for dry cow treatment, consists of an antimicrobial agent dispersed in a matrix of a low molecular weight polyester of glycolic and lactic acids, and shaped as a cylindrical bougie for facile insertion into the teat canal. Said polyester erodes by hydrolysis in the bioenvironment, providing a continuous release of the medication throughout the desired duration of the treatment. The low molecular weight polyesters have a glycolic acid content of about 60 to 80 mole percent, a lactic acid content of about 20 to 40 mole percent, and a molecular weight less than 2000.
    Type: Grant
    Filed: June 25, 1975
    Date of Patent: March 8, 1977
    Assignee: American Home Products Corporation
    Inventors: Gerald L. Reuter, Andrew G. Tsuk